Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page history. The notice about a lapse in government funding and the previous Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:51:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice about potential data inaccuracy and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:38:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option and minor wording/casing changes for QC labels (Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria), along with the No FEAR Act Data labeling. The Revision was updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:58:19.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Core study content and metadata were removed, including pamrevlumab, Idiopathic Pulmonary Fibrosis, related MeSH terms, and key study descriptions. This affects the communication of the study's purpose and details.
    Difference
    16%
    Check dated 2026-01-21T04:52:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page; this is a minor maintenance update that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:30:54.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section lists participating sites by state, and the previous separate per-state location headers have been removed, resulting in a new layout for site information.
    Difference
    2%
    Check dated 2025-12-23T21:08:07.000Z thumbnail image

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.